دورية أكاديمية

Neoadjuvant immunotherapy is safe before surgery in head and neck squamous cell carcinoma. Is it time to challenge the standard‐of‐care?

التفاصيل البيبلوغرافية
العنوان: Neoadjuvant immunotherapy is safe before surgery in head and neck squamous cell carcinoma. Is it time to challenge the standard‐of‐care?
المؤلفون: Gross, Neil D., Seiwert, Tanguy Y.
المصدر: Cancer ; volume 130, issue 6, page 846-847 ; ISSN 0008-543X 1097-0142
بيانات النشر: Wiley
سنة النشر: 2024
المجموعة: Wiley Online Library (Open Access Articles via Crossref)
الوصف: The incorporation of neoadjuvant immunotherapy is rapidly changing the standard‐of‐care for multiple cancers and is actively being explored in a phase 3 trial in head and neck squamous cell carcinoma. Although efficacy remains unknown, the safety of this approach is increasingly clear.
نوع الوثيقة: article in journal/newspaper
اللغة: English
DOI: 10.1002/cncr.35198
الإتاحة: https://doi.org/10.1002/cncr.35198Test
حقوق: http://onlinelibrary.wiley.com/termsAndConditions#vorTest
رقم الانضمام: edsbas.DBAC4890
قاعدة البيانات: BASE